FDA decree limits Genzyme drug distribution; WHO scolds EU for customs games delaying Indian drugs;

> Via consent decree, the FDA is restricting Genzyme's U.S. distribution of thyroid cancer drug Thyrogen. FDA Statement

> WHO calls EU on counterfeit/patent gamesmanship in slowing drug shipments from India. Article

> Canadian ointment and creams maker Contract Pharmaceuticals is closing its Buffalo, NY, facility by the end of 2011, eliminating 260 jobs. Article

> Inefficiency and lack of coordination between India's drug-purchasing and drug-manufacturing agencies has led to their merger by Health Minister Maithripala Sirisena. Article

> The Abbott Labs acquisition of India's Piramal Healthcare Solutions will drive more cross-border M&A activity, says ARC Advisory. Post

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.